8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

____________________

Date of report (Date of earliest event reported): June 29, 2010

Applied DNA Sciences, Inc

(Exact Name of Registrant as Specified in Charter)

Delaware (State or Other Jurisdiction of Incorporation) 002-90539 (Commission File Number) 59-2262718 (IRS Employer Identification No.)

25 Health Sciences Drive, Suite 113

Stony Brook, New York 11790

(Address of Principal Executive Offices) (Zip Code)

631-444- 8090

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

¨           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02.  Departure or Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)      On July 1, 2010, the Board of Directors of Applied DNA Sciences, Inc. (the “Company”) granted nonstatutory stock options under the Company’s 2005 Incentive Stock Plan to the Company’s principal executive officer, principal financial officer and one other named executive officer (the “executive officers”).

The Company will enter into an employee nonstatutory stock option agreement with each of the executive officers:

Name	Award Type	Number of Awards	Exercise Price	Award Plan
James A. Hayward	Nonstatutory Stock Options	10,000,000	$0.06	2005 Incentive Stock Plan
Kurt H. Jensen	Nonstatutory Stock Options	10,000,000	$0.06	2005 Incentive Stock Plan
Ming-Hwa Liang	Nonstatutory Stock Options	10,000,000	$0.06	2005 Incentive Stock Plan

The options granted to the executive officers vested with respect to 25% of the underlying shares on the date of grant, and the remaining will vest ratably each anniversary thereafter until fully vested on the third anniversary of the date of grant.

Item 8.01.  Other Events.

On June 29, 2010, the Company issued a press release to announce that it has customized its first series of “DNA Suits” made in Yorkshire, UK.  A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

On July 6, 2010, the Company issued a press release to announce that it has entered into an agreement with H.W. Sands Corp. (“HW Sands”) whereby the Company and HW Sands will jointly market and sell DNA security-based solutions to clients.  A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K.

Item 9.01.  Financial Statements and Exhibits.

(d)           Exhibits.

99.1	Press Release of Applied DNA Sciences, Inc., dated June 29, 2010.
99.2	Press Release of Applied DNA Sciences, Inc., dated July 6, 2010.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Applied DNA Sciences, Inc.

(Registrant)

By: /s/ James A. Hayward                                               

James A. Hayward

Chief Executive Officer

Date: July 6, 2010

EXHIBIT INDEX

Exhibit         Description

99.1	Press Release of Applied DNA Sciences, Inc., dated June 29, 2010.
99.2	Press Release of Applied DNA Sciences, Inc., dated July 6, 2010.

EX-99.1

Exhibit 99.1

Applied DNA Sciences Earns Its Stripes --

Textile-based SigNature DNA Anti-Counterfeiting Program Launched in UK

STONY BROOK, N.Y., June 29, 2010 /Market Wire/ -- Applied DNA Sciences, Inc. (OTCBB:APDN), a provider of DNA-based security solutions announced that it has successfully customized its first series of “DNA Suits” made in Yorkshire, UK. Each DNA suit was custommade from the finest woolen yarn, then woven and finished into a pinstripe fabric, and assembled by a master tailor. The DNA persists through multiple launderings, providing a definitive means to match the DNA mark to the bespoke suit. Importa nt to the utility of this marker to textile manufacturers, finishers and woven label assemblers, is that no retooling or change in production methods is required – integration of DNA in manufacturing is seamless.

Bill Macbeth, the Managing Director of the Textile Centre of Excellence stated, “DNA represents an important step in the evolution of our industry – both for existing processes and newproducts, as well as providing a tangible means to stimulate manufacturing jobs in our region. We believe that the exceptional quality and craftsmanship that Yorkshire companies pridethemselves on from yarn to woven fabric to a garment label, are valuable and worth protecting. We see Yorkshire as taking a technology leadership position by elevating the standard oftextiles made in Yorkshire and demonstrating that you do get superior garments when you can control the quality of the fabric itself.”

As part of the launch of the DNA Anti-Counterfeiting Program, APDN has received its first order from the Textile Centre of Excellence as part of its participation in the multi-year contract funded by the European Regional Development Fund and Yorkshire Forward. The initiating order (approximately $50,000) commences a three-year commitment of government of $1,500,000 to the program. “This contribution is designed to generate significant additional investment from the private sector, which should generate at least 2 million pounds over the three-year lifetime of the program,” stated Bill Macbeth, Managing Director, Textile Centre of Excellence. APDN is working with local companies to incorporate its botanical SigNature DNA markers into their products to protect premium textiles and apparel from counterfeiting and diversion, offering end-consumers with complete confidence in their purchases.

Recently, a bespoke men's jacket made by exclusive tailor, James Michelsberg was treated with SigNature DNA creating a unique "fingerprint" to prove its authenticity. The fibers for the cloth used to make the suit were immersed in SigNature DNA as they were put on the loom, before the fabric was finished. Mr. Michelsberg was recently quoted in The Yorkshire Evening Post as saying: "Counterfeiting is the biggest problem facing the textiles industry. There are people in India and China counterfeiting cloth, saying it’s woven in Yorkshire. We want to make sure they’re (customers) getting the genuine article.”

Andrew Knight from luxury weaver, John Cavendish, added, “It's tremendously exciting. With DNA you get authenticity, genuine goods and traceability - you can trace it back to the raw material, who wove it, who finished it and who sold the fabric. It's absolutely fantastic. As a local company it's something the industry has been crying out for."

Authentication issues plague the global economy. From high-tech synthetic yarns to wool fabrics, from cotton bed linen to outdoor fabrics and treatments, to “haute couture” fabric, the growth of counterfeiting is doubling the pace of total apparel market growth. Of the total value of counterfeit merchandise seized around the world, 63% related to the textile sector. According to the Global Market Report on Counterfeit Apparel (2008), industry analysts expect the proportion of counterfeiting in certain sectors to roughly double in the 2005 to 2014 period. In a multi-billion dollar market, this is not a small problem. The UK textile and clothing industry, the 9th largest manufacturing sector in the UK, generates over £18 billion/year in revenues. In the US, textile and apparel is the third largest exporter and represents at least $90 billion in revenues per year. APDN is offering the best and most cost effective solution to-date, a solution that cannot be copied, reverse engineered or otherwise compromised.

“Whether it is the finest worsted wools from Yorkshire, super fine merino from Australia, pure cashmere, or recycled polyester the demand to protect the integrity and authenticity of products at the source is growing and we are very pleased to be able to provide a practical solution to address this most pressing need,” commented Dr. James Hayward, President and CEO of APDN. “Applied DNA has now truly earned its stripes.”

About APDN

APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to

authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping™ by detecting genomic DNA in natural materials to

authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute

perpetrators. To learn more, go to www.adnas.com where APDN routinely posts all press releases.

The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 23, 2009 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

SOURCE Applied DNA Sciences, Inc.

INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848

MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848

FCMN Contact: info@adnas.com

Web site: http://www.adnas.com

EX-99.2

Exhibit 99.2

Applied DNA Sciences and H.W. Sands Corp. Sign Agreement to Jointly Market Security Technologies

STONY BROOK, N.Y., July 6, 2010 /Market Wire/ -- Applied DNA Sciences, Inc. (OTC BB: APDN), a provider of DNA-based security solutions, and H.W. Sands Corp., a trusted leader in the global market for advancing security, chemical and card industries, announced the signing of an Agreement to jointly market and sell DNA security-based solutions to clients that are dedicated to protecting their products, supply chains and end consumers from counterfeiting and gray market diversion.

H.W. Sands Corp. has grown to be a trusted leader in the global marketplace since 1983; doing business in more than 30 countries with a distribution network in Japan, China, Korea and Europe. Recently, H.W. Sands Corp. launched a new division in response to the increased demand for security inks and dyes, with the inclusion of DNA as the definitive means for authentication. With its own dedicated team focused on the growing need for the best-in-breed security solutions, H.W. Sands Security will be working with APDN to jointly market and sell forensic DNA markers and authentication services in targeted industry verticals. H.W. Sands Security is currently in negotiations with potential distributors in Brazil, South America, Australia and India. H.W. Sands currently has existing distributors for Japan, China, Korea and Europe. The company 217;s expertise is in the manufacture of a variety of dyes, inks, and chemical solutions for screen, gravure and flexographic printing. They service Fortune 100 and 500 clients all over the world and renowned for their high quality custom dyes and inks used in hundreds of millions products.

“We are all about delivering outstanding value to our customers by offering best-in-breed DNA technology that secures brand and inspires consumer confidence. With more uncertainty as to whether products are truly genuine, comes the opportunity to provide the most secure and interactive packaging and documentation available on the market. That’s why partnering with Applied DNA Sciences makes perfect sense. There is no doubt in my mind that forensic level marking and authentication will soon become an essential component in brand management,” stated Jeffrey Strahl, Vice President, H.W .Sands Security; the security division of H.W. Sands Corp.

“Our sales and marketing reach is greatly enhanced by our partnership with H.W. Sands Corp. They have significant expertise and reach in multiple industry verticals that complement our efforts, and also expand our growth and market penetration in Asia and abroad,” commented James A. Hayward, CEO of APDN.

About H.W. Sands

H. W. Sands Corp. is a worldwide leader in the design and manufacture of products for the Imaging Industry with a primary focus on the Security, Transaction Card, Electrophotographic, Display/OLED, Ink Jet and Pre-sensitized Printing Plate markets. Established in 1983, H.W. Sands Corp. provides research, development and commercialization of high-value, custom and commercial dyes, chemicals and corollary products that support customers’ product differentiation, thereby increasing brand value and overall profitability. H.W. Sands Corp. is headquartered in Jupiter, Florida and for more information, visitwww.hwsands.com.

About APDN

APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping™ by detecting genomic DNA in natural materials to authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute perpetrators. To learn more, go to (www.adnas.com).

The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 23, 2009 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looki ng statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

SOURCE Applied DNA Sciences, Inc.

INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848

MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848

FCMN Contact: info@adnas.com

Web site: http://www.adnas.com